| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |